MedTrace Logo

BicMag Study - Improving Mineral Buffering Capacity in Dialysis Patients

NCT07663279 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2026-06-23

No results posted yet for this study

Summary

The BicMag study is a prospective, randomized, controlled cross-over study that aims to examine the potential additive effect of a dialysate enriched with both bicarbonate and magnesium on mineral buffering capacity in the blood of chronic hemodialysis patients.

Conditions

Interventions

OTHER

D-Standard

Center's standard dialysate containing 32 mmol/L bicarbonate and 0.5 mmol/L magnesium

OTHER

D-Bic

Dialysate bicarbonate increased to 37 mmol/L; dialysate magnesium held at 0.5 mmol/L

OTHER

D-Mag

Dialysate magnesium increased to 1.0 mmol/L; dialysate bicarbonate held at 32 mmol/L

OTHER

D-BicMag

Dialysate bicarbonate increased to 37 mmol/L; dialysate magnesium increased to 1.0 mmol/L

Sponsors & Collaborators

  • Elisabethinen Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2029-10-31
Completion
2029-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663279 on ClinicalTrials.gov